Literature DB >> 3318021

Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa.

B M Greenwood1, A K Bradley, A M Greenwood, P Byass, K Jammeh, K Marsh, S Tulloch, F S Oldfield, R Hayes.   

Abstract

Mortality and morbidity from malaria were measured among 3000 children under the age of 7 years in a rural area of The Gambia, West Africa. Using a post-mortem questionnaire technique, malaria was identified as the probable cause of 4% of infant deaths and of 25% of deaths in children aged 1 to 4 years. The malaria mortality rate was 6.3 per 1000 per year in infants and 10.7 per 1000 per year in children aged 1 to 4 years. Morbidity surveys suggested that children under the age of 7 years experienced about one clinical episode of malaria per year. Calculation of attributable fractions showed that malaria may be responsible for about 40% of episodes of fever in children. Although the overall level of parasitaemia showed little seasonal variation, the clinical impact of malaria was highly seasonal; all malaria deaths and a high proportion of febrile episodes were recorded during a limited period at the end of the rainy season.

Entities:  

Mesh:

Year:  1987        PMID: 3318021     DOI: 10.1016/0035-9203(87)90170-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  141 in total

1.  The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria.

Authors:  Morris O Makobongo; George Riding; Huji Xu; Chakrit Hirunpetcharat; Dianne Keough; John de Jersey; Peter Willadsen; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Intracranial hypertension in Africans with cerebral malaria.

Authors:  C R Newton; J Crawley; A Sowumni; C Waruiru; I Mwangi; M English; S Murphy; P A Winstanley; K Marsh; F J Kirkham
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

3.  Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.

Authors:  D J Conway; B M Greenwood; J S McBride
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Reconciling national treatment policies and drug regulation in Kenya.

Authors:  Abdinasir A Amin; Tom Walley; Gilbert O Kokwaro; Peter A Winstanley; Robert W Snow
Journal:  Health Policy Plan       Date:  2007-01-15       Impact factor: 3.344

6.  Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled trial.

Authors:  O Müller; H Becher; A B van Zweeden; Y Ye; D A Diallo; A T Konate; A Gbangou; B Kouyate; M Garenne
Journal:  BMJ       Date:  2001-06-30

Review 7.  Antimalarial drug quality in Africa.

Authors:  A A Amin; G O Kokwaro
Journal:  J Clin Pharm Ther       Date:  2007-10       Impact factor: 2.512

8.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Parasite burden and severity of malaria in Tanzanian children.

Authors:  Bronner P Gonçalves; Chiung-Yu Huang; Robert Morrison; Sarah Holte; Edward Kabyemela; D Rebecca Prevots; Michal Fried; Patrick E Duffy
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

10.  Artemisinin-based combination therapy: knowledge and perceptions of patent medicine dealers in Owerri Metropolis, Imo State, Nigeria and implications for compliance with current malaria treatment protocol.

Authors:  Uchechukwu Madukaku Chukwuocha; Geoffrey Chima Nwakwuo; Ikechukwu Mmerole
Journal:  J Community Health       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.